-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GAT+iX3SD5x4S4EE1yMtZ+7Jd3j6ATyN38h0MkZ6nz6YMD3gC+8K0yivmqia6qMi azxPdkAl9ksb2vmXs+g76Q== 0000872610-97-000005.txt : 19971014 0000872610-97-000005.hdr.sgml : 19971014 ACCESSION NUMBER: 0000872610-97-000005 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19971010 SROS: NONE FILER: COMPANY DATA: COMPANY CONFORMED NAME: INVITRO INTERNATIONAL / CENTRAL INDEX KEY: 0000872610 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330149560 STATE OF INCORPORATION: CA FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 15-12G SEC ACT: SEC FILE NUMBER: 000-19241 FILM NUMBER: 97693888 BUSINESS ADDRESS: STREET 1: 16632 MILLIKEN AVE CITY: IRVINE STATE: CA ZIP: 92714 BUSINESS PHONE: 7148518356 MAIL ADDRESS: STREET 1: 16632 MILLIKEN AVE CITY: IRVINE STATE: CA ZIP: 92914 FORMER COMPANY: FORMER CONFORMED NAME: ROPAK LABORATORIES DATE OF NAME CHANGE: 19600201 15-12G 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934. Commission File Number 0-19241 INVITRO INTERNATIONAL --------------------------------------------------------------------------- (Exact name of small business issuer as specified in its charter) 16632 Millikan Avenue, Irvine, California 92606 Telephone (714) 851-8356 --------------------------------------------------------------------------- (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Common Stock, without par value --------------------------------------------------------------------------- (Title of each class of securities covered by this Form) None --------------------------------------------------------------------------- (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports: Rule 12g-4(a)(1)(i) [X] Rule 12g-4(a)(1)(ii) [X] Rule 12g-4(a)(2)(i) [ ] Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(1)(i) [ ] Rule 12h-3(b)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ] Rule 15d-6 [ ] Approximate number of holders of record as of the certification or notice date: 288 ------- Pursuant to the requirements of the Securities Exchange Act of 1934, INVITRO INTERNATIONAL has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person. DATE: October 10, 1997 INVITRO INTERNATIONAL (Registrant) By: /s/ William M. Curtis --------------------------- William M. Curtis, Secretary -----END PRIVACY-ENHANCED MESSAGE-----